AIM ImmunoTech Inc. (AIMI) financials · rev $170.0K
AIM ImmunoTech Inc. (AIMI) rev $170.0K.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $170.0K | $202.0K | $141.0K | $135.0K |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| Net Income | -$17.3M | -$29.0M | -$19.4M | -$19.1M |
| EPS (Diluted) | $-0.31 | $-0.60 | $-0.40 | $0.00 |
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | $8.6M | $19.4M | $40.5M |
| Current Assets | $0 | $0 | $0 |
| Cash & Equivalents | $1.7M | $5.4M | $27.1M |
| Inventory | $0 | $0 | $0 |
| PP&E | $0 | $0 | $0 |
| Total Liabilities | $9.9M | $9.1M | $2.0M |
| Current Liabilities | $0 | $0 | $0 |
| Short-term Debt | $0 | $0 | $0 |
| Long-term Debt | $0 | $0 | $0 |
| Total Debt | $0 | $0 | $0 |
| Shareholders' Equity | $0 | $0 | $0 |
| Retained Earnings | $0 | $0 | $0 |
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Operating Cash Flow | -$14.9M | -$21.3M | -$16.1M | -$14.0M |
| CapEx | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $4.7M | -$832.0K | $11.0M | -$631.0K |
| Financing Cash Flow | $6.4M | $485.0K | $80.0K | $8.2M |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Net Change in Cash | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |
FAQ
What is AIMI P/E and revenue?
AIM ImmunoTech Inc. (AIMI) rev $170.0K.
What is AIMI revenue?
AIM ImmunoTech Inc. last cached revenue is $170.0K (FY2024).
Is AIMI profitable?
AIM ImmunoTech Inc. last cached net income is -$17.3M.
What are AIMI total assets?
AIM ImmunoTech Inc. last cached total assets are $8.6M.
What is AIMI free cash flow?
AIM ImmunoTech Inc. last cached free cash flow is $0.
Not investment advice. Cached statements, not a live tape.